Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 84 entries
Sorted by: Best Match Show Resources per page
Apixaban and oral implications.

Journal of clinical and experimental dentistry

Lopez-Galindo M, Bagán JV.
PMID: 26535102
J Clin Exp Dent. 2015 Oct 01;7(4):e528-34. doi: 10.4317/jced.52470. eCollection 2015 Oct.

BACKGROUND: Thrombotic disorders remain a leading cause of death in the Western world, and in this regard a number of anticoagulation treatment have been used, including heparins, fondaparinux, vitamin K antagonists (warfarin, acenocoumarol), and new oral anticoagulants such as...

Cite
Lopez-Galindo M, Bagán JV. Apixaban and oral implications. J Clin Exp Dent. 2015;7(4):e528-34doi: 10.4317/jced.52470.
Lopez-Galindo, M., & Bagán, J. V. (2015). Apixaban and oral implications. Journal of clinical and experimental dentistry, 7(4), e528-34. https://doi.org/10.4317/jced.52470
Lopez-Galindo, Monica, and Bagán, Jose V. "Apixaban and oral implications." Journal of clinical and experimental dentistry vol. 7,4 (2015): e528-34. doi: https://doi.org/10.4317/jced.52470
Lopez-Galindo M, Bagán JV. Apixaban and oral implications. J Clin Exp Dent. 2015 Oct 01;7(4):e528-34. doi: 10.4317/jced.52470. eCollection 2015 Oct. PMID: 26535102; PMCID: PMC4628810.
Copy Download .nbib Format: NLM
Spontaneous epidural hematoma of the spine associated with oral anticoagulants: 3 Case Studies.

International journal of surgery case reports

Tawk C, El Hajj Moussa M, Zgheib R, Nohra G.
PMID: 26074484
Int J Surg Case Rep. 2015;13:8-11. doi: 10.1016/j.ijscr.2015.05.022. Epub 2015 May 29.

INTRODUCTION: Spontaneous epidural hematoma of the spine (SEHS) is an extremely rare entity. Patients known to have thrombophilia or on anticoagulant drugs are the most affected. It is generally caused by a rupture of the postero-internal vertebral venous plexus...

Cite
Tawk C, El Hajj Moussa M, Zgheib R, et al. Spontaneous epidural hematoma of the spine associated with oral anticoagulants: 3 Case Studies. Int J Surg Case Rep. 2015;13:8-11doi: 10.1016/j.ijscr.2015.05.022.
Tawk, C., El Hajj Moussa, M., Zgheib, R., & Nohra, G. (2015). Spontaneous epidural hematoma of the spine associated with oral anticoagulants: 3 Case Studies. International journal of surgery case reports, 138-11. https://doi.org/10.1016/j.ijscr.2015.05.022
Tawk, C, et al. "Spontaneous epidural hematoma of the spine associated with oral anticoagulants: 3 Case Studies." International journal of surgery case reports vol. 13 (2015): 8-11. doi: https://doi.org/10.1016/j.ijscr.2015.05.022
Tawk C, El Hajj Moussa M, Zgheib R, Nohra G. Spontaneous epidural hematoma of the spine associated with oral anticoagulants: 3 Case Studies. Int J Surg Case Rep. 2015;13:8-11. doi: 10.1016/j.ijscr.2015.05.022. Epub 2015 May 29. PMID: 26074484; PMCID: PMC4529632.
Copy Download .nbib Format: NLM
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation.

Cardiology and therapy

Pinyol C, Cepeda JM, Roldan I, Roldan V, Jimenez S, Gonzalez P, Soto J.
PMID: 27457613
Cardiol Ther. 2016 Dec;5(2):171-186. doi: 10.1007/s40119-016-0066-2. Epub 2016 Jul 25.

INTRODUCTION: Economic evaluations are becoming increasingly important due to limitations in economic resources, the expense of many new treatments, the need to allocate health spending as effectively as possible, and the need to inform decision makers. Based on the...

Cite
Pinyol C, Cepeda JM, Roldan I, et al. A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation. Cardiol Ther. 2016;5(2):171-186doi: 10.1007/s40119-016-0066-2.
Pinyol, C., Cepeda, J. M., Roldan, I., Roldan, V., Jimenez, S., Gonzalez, P., & Soto, J. (2016). A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation. Cardiology and therapy, 5(2), 171-186. https://doi.org/10.1007/s40119-016-0066-2
Pinyol, Carme, et al. "A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation." Cardiology and therapy vol. 5,2 (2016): 171-186. doi: https://doi.org/10.1007/s40119-016-0066-2
Pinyol C, Cepeda JM, Roldan I, Roldan V, Jimenez S, Gonzalez P, Soto J. A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation. Cardiol Ther. 2016 Dec;5(2):171-186. doi: 10.1007/s40119-016-0066-2. Epub 2016 Jul 25. PMID: 27457613; PMCID: PMC5125108.
Copy Download .nbib Format: NLM
Severe rhabdomyolysis secondary to simvastatin and acenocoumarol.

European journal of internal medicine

Salinas A, Solís J, Rico LA.
PMID: 17338976
Eur J Intern Med. 2007 Mar;18(2):165. doi: 10.1016/j.ejim.2006.07.030.

No abstract available.

Cite
Salinas A, Solís J, Rico LA. Severe rhabdomyolysis secondary to simvastatin and acenocoumarol. Eur J Intern Med. 2007;18(2):165doi: 10.1016/j.ejim.2006.07.030.
Salinas, A., Solís, J., & Rico, L. A. (2007). Severe rhabdomyolysis secondary to simvastatin and acenocoumarol. European journal of internal medicine, 18(2), 165. https://doi.org/10.1016/j.ejim.2006.07.030
Salinas, A, et al. "Severe rhabdomyolysis secondary to simvastatin and acenocoumarol." European journal of internal medicine vol. 18,2 (2007): 165. doi: https://doi.org/10.1016/j.ejim.2006.07.030
Salinas A, Solís J, Rico LA. Severe rhabdomyolysis secondary to simvastatin and acenocoumarol. Eur J Intern Med. 2007 Mar;18(2):165. doi: 10.1016/j.ejim.2006.07.030. PMID: 17338976.
Copy Download .nbib Format: NLM
Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products.

Evidence-based complementary and alternative medicine : eCAM

Paoletti A, Gallo E, Benemei S, Vietri M, Lapi F, Volpi R, Menniti-Ippolito F, Gori L, Mugelli A, Firenzuoli F, Vannacci A.
PMID: 21274401
Evid Based Complement Alternat Med. 2011;2011:612150. doi: 10.1155/2011/612150. Epub 2011 Jan 09.

Introduction. The safety of vitamin K antagonists (VKA) use can be compromised by many popular herbal supplements taken by individuals. The literature reports that 30% of warfarin-treated patients self-medicates with herbs. Possible interactions represent an health risk. We aimed...

Cite
Paoletti A, Gallo E, Benemei S, et al. Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products. Evid Based Complement Alternat Med. 2011;2011:612150doi: 10.1155/2011/612150.
Paoletti, A., Gallo, E., Benemei, S., Vietri, M., Lapi, F., Volpi, R., Menniti-Ippolito, F., Gori, L., Mugelli, A., Firenzuoli, F., & Vannacci, A. (2011). Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products. Evidence-based complementary and alternative medicine : eCAM, 2011612150. https://doi.org/10.1155/2011/612150
Paoletti, Angelica, et al. "Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products." Evidence-based complementary and alternative medicine : eCAM vol. 2011 (2011): 612150. doi: https://doi.org/10.1155/2011/612150
Paoletti A, Gallo E, Benemei S, Vietri M, Lapi F, Volpi R, Menniti-Ippolito F, Gori L, Mugelli A, Firenzuoli F, Vannacci A. Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products. Evid Based Complement Alternat Med. 2011;2011:612150. doi: 10.1155/2011/612150. Epub 2011 Jan 09. PMID: 21274401; PMCID: PMC3025393.
Copy Download .nbib Format: NLM
Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxban.

Expert review of pharmacoeconomics & outcomes research

Ivanovic N, Beinema M, Brouwers JR, Naunton M, Postma MJ.
PMID: 20528430
Expert Rev Pharmacoecon Outcomes Res. 2007 Feb;7(1):49-58. doi: 10.1586/14737167.7.1.49.

This paper reviews the clinical and pharmacoeconomic studies that have been conducted within Europe for patients undergoing elective hip-replacement surgery. Additionally, we offer a perspective on the possible future clinical use of new agents in orthopedic surgery, such as...

Cite
Ivanovic N, Beinema M, Brouwers JR, et al. Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxban. Expert Rev Pharmacoecon Outcomes Res. 2007;7(1):49-58doi: 10.1586/14737167.7.1.49.
Ivanovic, N., Beinema, M., Brouwers, J. R., Naunton, M., & Postma, M. J. (2007). Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxban. Expert review of pharmacoeconomics & outcomes research, 7(1), 49-58. https://doi.org/10.1586/14737167.7.1.49
Ivanovic, Natasa, et al. "Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxban." Expert review of pharmacoeconomics & outcomes research vol. 7,1 (2007): 49-58. doi: https://doi.org/10.1586/14737167.7.1.49
Ivanovic N, Beinema M, Brouwers JR, Naunton M, Postma MJ. Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxban. Expert Rev Pharmacoecon Outcomes Res. 2007 Feb;7(1):49-58. doi: 10.1586/14737167.7.1.49. PMID: 20528430.
Copy Download .nbib Format: NLM
Pharmacogenetics of anticoagulants.

Human genomics and proteomics : HGP

Rane A, Lindh JD.
PMID: 20981234
Hum Genomics Proteomics. 2010 Sep 13;2010:754919. doi: 10.4061/2010/754919.

Warfarin, acenocoumarol, and phenprocoumon are among the major anticoagulant drugs worldwide. Because of their low therapeutic index and serious adverse reactions (ADRs), their wide use, and their varying kinetics and pharmacogenetic dependence, it is of great importance to explore...

Cite
Rane A, Lindh JD. Pharmacogenetics of anticoagulants. Hum Genomics Proteomics. 2010;2010:754919doi: 10.4061/2010/754919.
Rane, A., & Lindh, J. D. (2010). Pharmacogenetics of anticoagulants. Human genomics and proteomics : HGP, 2010754919. https://doi.org/10.4061/2010/754919
Rane, Anders, and Lindh, Jonatan D. "Pharmacogenetics of anticoagulants." Human genomics and proteomics : HGP vol. 2010 (2010): 754919. doi: https://doi.org/10.4061/2010/754919
Rane A, Lindh JD. Pharmacogenetics of anticoagulants. Hum Genomics Proteomics. 2010 Sep 13;2010:754919. doi: 10.4061/2010/754919. PMID: 20981234; PMCID: PMC2958670.
Copy Download .nbib Format: NLM
Alternative to oral dicoumarin anticoagulants: Considerations in dental care.

Journal of clinical and experimental dentistry

Mingarro-de-León A, Chaveli-López B.
PMID: 24455094
J Clin Exp Dent. 2013 Dec 01;5(5):e273-8. doi: 10.4317/jced.51226. eCollection 2013 Dec 01.

INTRODUCTION: For over 50 years, vitamin K antagonists such as warfarin (Aldocumar®) and acenocoumarol (Sintrom®) have been the gold standard for reducing the risk of cerebrovascular events. In the last 5 years alternative anticoagulants have been evaluated that act...

Cite
Mingarro-de-León A, Chaveli-López B. Alternative to oral dicoumarin anticoagulants: Considerations in dental care. J Clin Exp Dent. 2013;5(5):e273-8doi: 10.4317/jced.51226.
Mingarro-de-León, A., & Chaveli-López, B. (2013). Alternative to oral dicoumarin anticoagulants: Considerations in dental care. Journal of clinical and experimental dentistry, 5(5), e273-8. https://doi.org/10.4317/jced.51226
Mingarro-de-León, Ana, and Chaveli-López, Begonya. "Alternative to oral dicoumarin anticoagulants: Considerations in dental care." Journal of clinical and experimental dentistry vol. 5,5 (2013): e273-8. doi: https://doi.org/10.4317/jced.51226
Mingarro-de-León A, Chaveli-López B. Alternative to oral dicoumarin anticoagulants: Considerations in dental care. J Clin Exp Dent. 2013 Dec 01;5(5):e273-8. doi: 10.4317/jced.51226. eCollection 2013 Dec 01. PMID: 24455094; PMCID: PMC3892260.
Copy Download .nbib Format: NLM
Relationship between drug interactions and drug-related negative clinical outcomes.

Pharmacy practice

Cremades J, Gonzalo M, Arrebola I.
PMID: 25147590
Pharm Pract (Granada). 2009 Jan;7(1):34-9. doi: 10.4321/s1886-36552009000100005. Epub 2009 Mar 15.

UNLABELLED: Drug interactions may represent an iatrogenic risk that should be controlled in community pharmacies at the dispensing level.AIM: We analyzed the association between potential drug-drug interactions (DDIs) and negative clinical outcomes.METHODS: WE USED DISPENSING DATA FROM TWO COMMUNITY...

Cite
Cremades J, Gonzalo M, Arrebola I. Relationship between drug interactions and drug-related negative clinical outcomes. Pharm Pract (Granada). 2009;7(1):34-9doi: 10.4321/s1886-36552009000100005.
Cremades, J., Gonzalo, M., & Arrebola, I. (2009). Relationship between drug interactions and drug-related negative clinical outcomes. Pharmacy practice, 7(1), 34-9. https://doi.org/10.4321/s1886-36552009000100005
Cremades, Javier, et al. "Relationship between drug interactions and drug-related negative clinical outcomes." Pharmacy practice vol. 7,1 (2009): 34-9. doi: https://doi.org/10.4321/s1886-36552009000100005
Cremades J, Gonzalo M, Arrebola I. Relationship between drug interactions and drug-related negative clinical outcomes. Pharm Pract (Granada). 2009 Jan;7(1):34-9. doi: 10.4321/s1886-36552009000100005. Epub 2009 Mar 15. PMID: 25147590; PMCID: PMC4139754.
Copy Download .nbib Format: NLM
The new oral anticoagulants.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Verheugt FW.
PMID: 20657677
Neth Heart J. 2010 Jun;18(6):314-8. doi: 10.1007/BF03091782.

In patients with nonvalvular atrial fibrillation oral anticoagulation with the vitamin K antagonists acenocoumarol, phenprocoumon and warfarin reduces the risk of stroke by more than 60%, whereas single or double antiplatelet therapy is much less effective and sometimes associated...

Cite
Verheugt FW. The new oral anticoagulants. Neth Heart J. 2010;18(6):314-8doi: 10.1007/BF03091782.
Verheugt, F. W. (2010). The new oral anticoagulants. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 18(6), 314-8. https://doi.org/10.1007/BF03091782
Verheugt, F W A. "The new oral anticoagulants." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 18,6 (2010): 314-8. doi: https://doi.org/10.1007/BF03091782
Verheugt FW. The new oral anticoagulants. Neth Heart J. 2010 Jun;18(6):314-8. doi: 10.1007/BF03091782. PMID: 20657677; PMCID: PMC2881348.
Copy Download .nbib Format: NLM
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.

Thrombosis journal

Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS.
PMID: 24053656
Thromb J. 2013 Sep 20;11(1):21. doi: 10.1186/1477-9560-11-21.

BACKGROUND: Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring...

Cite
Prins MH, Lensing AW, Bauersachs R, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013;11(1):21doi: 10.1186/1477-9560-11-21.
Prins, M. H., Lensing, A. W., Bauersachs, R., van Bellen, B., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., Raskob, G. E., Berkowitz, S. D., Wells, P. S. (2013). Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thrombosis journal, 11(1), 21. https://doi.org/10.1186/1477-9560-11-21
Prins, Martin H, et al. "Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies." Thrombosis journal vol. 11,1 (2013): 21. doi: https://doi.org/10.1186/1477-9560-11-21
Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013 Sep 20;11(1):21. doi: 10.1186/1477-9560-11-21. PMID: 24053656; PMCID: PMC3850944.
Copy Download .nbib Format: NLM
The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations.

Personalized medicine

Kirchheiner J, Tsahuridu M, Jabrane W, Roots I, Brockmöller J.
PMID: 29793229
Per Med. 2004 Dec;1(1):63-84. doi: 10.1517/17410541.1.1.63.

CYP2C9 is the major human enzyme of the cytochrome P450 2C subfamily and metabolizes approximately 10% of all therapeutically relevant drugs. Two inherited SNPs termed CYP2C9*2 (Arg144Cys) and *3 (Ile359Leu) are known to affect catalytic function. Numerous rare or...

Cite
Kirchheiner J, Tsahuridu M, Jabrane W, et al. The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations. Per Med. 2004;1(1):63-84doi: 10.1517/17410541.1.1.63.
Kirchheiner, J., Tsahuridu, M., Jabrane, W., Roots, I., & Brockmöller, J. (2004). The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations. Personalized medicine, 1(1), 63-84. https://doi.org/10.1517/17410541.1.1.63
Kirchheiner, Julia, et al. "The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations." Personalized medicine vol. 1,1 (2004): 63-84. doi: https://doi.org/10.1517/17410541.1.1.63
Kirchheiner J, Tsahuridu M, Jabrane W, Roots I, Brockmöller J. The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations. Per Med. 2004 Dec;1(1):63-84. doi: 10.1517/17410541.1.1.63. PMID: 29793229.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 84 entries